TABLE 11.
Selected Rat Brain or RBC AChE inhibitiona for developmental period of exposure | ||||
---|---|---|---|---|
GD 9–12 (dams exposed) | GD 17–20 (dams exposed) | PND 1–4 (pups exposed) | PND 10–16 or 11–14 (pups exposed) | |
CPF s.c. exposures (Brain AChE inhibition in rat offspring) | 1 and 5 mg/kg: Not measured | 1 mg/kg: 0 (24 hr) 2 mg/kg: 20% (24 hr) (Qiao et al., 2002) 5 mg/kg: 50% (24 hr) (Qiao et al., 2002) |
1 mg/kg: 25% (24 hr) Song et al., 1997 1 mg/kg: 75% (2 hr after PND1 dose) Dam et al., 2000 |
PND 10–16 5 mg/kg 73% (4 hr)Carr and Nail, 2008 PND 11–14 5 mg/kg >65% (24 hr) Song et al., 1997 |
CPF oral exposures (Brain AChE inhibition in rat offspring) | GD 6–20 1 mg/kg: 0 (4 hr) 5 mg/kg: 60% (4 hr) (Mattsson et al., 2000) |
PND 10–16 5 mg/kg >58% (4hr) Carr and Nail, 2008 |
||
CPF oral exposures (RBC AChE inhibition in dams) | GD 6–20 0.3 mg/kg: >25% dam RBC AChE Inhibition (4 hr) 1 mg/kg: >80% dam RBC AChE inhibition (4 hr) (Mattsson et al., 2000) |
Greatest effect from selected publication was reported, with 0 indicating no effect